{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:22:35Z","timestamp":1777105355686,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S020470\/1"],"award-info":[{"award-number":["MR\/S020470\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.clon.2019.12.008","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T16:08:58Z","timestamp":1578499738000},"page":"e135-e144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England"],"prefix":"10.1016","volume":"32","author":[{"given":"J.M.","family":"Boyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kuryba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.E.","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"van der Meulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2019.12.008_bib1","series-title":"National Bowel cancer audit annual report","year":"2017"},{"issue":"7","key":"10.1016\/j.clon.2019.12.008_bib2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/ijc.31168","article-title":"Administration of adjuvant chemotherapy for stage II\u2013III colon cancer patients: a European population-based study","volume":"142","author":"Babaei","year":"2018","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.clon.2019.12.008_bib3","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.1990.03450110090034","article-title":"Adjuvant therapy for patients with colon and rectal cancer","volume":"264","year":"1990","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.clon.2019.12.008_bib5","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1002\/cncr.30181","article-title":"Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer","volume":"122","author":"Casadaban","year":"2016","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.clon.2019.12.008_bib6","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1200\/JCO.2011.39.6937","article-title":"Adherence to stage-specific treatment guidelines for patients with colon cancer","volume":"30","author":"Chagpar","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2019.12.008_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.surg.2015.03.057","article-title":"Opportunity lost: adjuvant chemotherapy in patients with stage III colon cancer remains underused","volume":"158","author":"Becerra","year":"2015","journal-title":"Surgery"},{"issue":"15","key":"10.1016\/j.clon.2019.12.008_bib8","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1002\/cncr.30691","article-title":"Management of stage III colon cancer in the elderly: practice patterns and outcomes in the general population","volume":"123","author":"Merchant","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clon.2019.12.008_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clon.2019.12.008_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/annonc\/mdu253","article-title":"Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013","volume":"26","author":"Papamichael","year":"2015","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.clon.2019.12.008_bib11","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/cncr.23958","article-title":"Rates and predictors of chemotherapy use for stage III colon cancer","volume":"113","author":"Etzioni","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2019.12.008_bib12","series-title":"The age old excuse: the under treatment of older cancer patients","year":"2012"},{"key":"10.1016\/j.clon.2019.12.008_bib13","doi-asserted-by":"crossref","first-page":"g1614","DOI":"10.1136\/bmj.g1614","article-title":"Ageism in cancer care","volume":"348","author":"Lawler","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.clon.2019.12.008_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-2026-y","article-title":"A\u00a0systematic review of geographical variation in access to chemotherapy","volume":"16","author":"Chamberlain","year":"2015","journal-title":"BMC Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.clon.2019.12.008_bib15","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.ejso.2010.05.026","article-title":"Disparities in quality of care for colon cancer between hospitals in the Netherlands","volume":"36","author":"Elferink","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clon.2019.12.008_bib17","author":"NHS Digital"},{"issue":"6","key":"10.1016\/j.clon.2019.12.008_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2019.12.008_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0019-5049.79879","article-title":"American Society of Anaesthesiologists physical status classification","volume":"55","author":"Daabiss","year":"2011","journal-title":"Indian J Anaesth"},{"issue":"5","key":"10.1016\/j.clon.2019.12.008_bib21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/bjs.6930","article-title":"Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score","volume":"97","author":"Armitage","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.clon.2019.12.008_bib22","series-title":"Official statistics","author":"English indices of deprivation","year":"2010"},{"issue":"4","key":"10.1016\/j.clon.2019.12.008_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"8","key":"10.1016\/j.clon.2019.12.008_bib26","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/sim.1970","article-title":"Funnel plots for comparing institutional performance","volume":"24","author":"Spiegelhalter","year":"2005","journal-title":"Stat Med"},{"issue":"20","key":"10.1016\/j.clon.2019.12.008_bib27","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1002\/cncr.25250","article-title":"Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment","volume":"116","author":"Winget","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clon.2019.12.008_bib28","first-page":"141","article-title":"Comparison of treatment received versus long-standing guidelines for stage III colon and stage II\/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004","volume":"8","author":"Cree","year":"2009","journal-title":"Clin Colorectal Cancer"},{"issue":"8","key":"10.1016\/j.clon.2019.12.008_bib29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00066-004-1260-z","article-title":"Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry","volume":"180","author":"Fietkau","year":"2004","journal-title":"Strahlenther Onkol"},{"issue":"8","key":"10.1016\/j.clon.2019.12.008_bib30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.dld.2012.12.019","article-title":"Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy","volume":"45","author":"Bouvier","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.clon.2019.12.008_bib31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/annonc\/mdi159","article-title":"Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity","volume":"16","author":"Lemmens","year":"2005","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clon.2019.12.008_bib32","doi-asserted-by":"crossref","first-page":"O51","DOI":"10.1111\/codi.12442","article-title":"Deprivation and access to treatment for colorectal cancer in Southeast Scotland 2003\u20132009","volume":"16","author":"Paterson","year":"2014","journal-title":"Colorectal Dis"},{"issue":"3","key":"10.1016\/j.clon.2019.12.008_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/bjc.2014.300","article-title":"Identifying patients at risk of emergency admission for colorectal cancer","volume":"111","author":"Wallace","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2019.12.008_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12911-015-0175-1","article-title":"Assessing measures of comorbidity and functional status for risk adjustment to compare hospital performance for colorectal cancer surgery: a retrospective data-linkage study","volume":"15","author":"Dobbins","year":"2015","journal-title":"BMC Med Inform Decis Mak"},{"issue":"9","key":"10.1016\/j.clon.2019.12.008_bib35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/jnci\/djj159","article-title":"Completion of therapy by Medicare patients with stage III colon cancer","volume":"98","author":"Dobie","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.clon.2019.12.008_bib36","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.surg.2016.11.024","article-title":"Laparoscopic colectomy for cancer: improved compliance with guidelines for chemotherapy and survival","volume":"161","author":"Kim","year":"2017","journal-title":"Surgery"},{"issue":"16","key":"10.1016\/j.clon.2019.12.008_bib37","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/dji241","article-title":"Explaining black\u2013white differences in receipt of recommended colon cancer treatment","volume":"97","author":"Baldwin","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.clon.2019.12.008_bib38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1200\/JCO.2002.20.5.1192","article-title":"Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer","volume":"20","author":"Potosky","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.clon.2019.12.008_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/jech.53.12.775","article-title":"Variation in the provision of chemotherapy for colorectal cancer","volume":"53","author":"McLeod","year":"1999","journal-title":"J\u00a0Epidemiol Commun Health"},{"key":"10.1016\/j.clon.2019.12.008_bib40","doi-asserted-by":"crossref","first-page":"d1513","DOI":"10.1136\/bmj.d1513","article-title":"Time to tackle unwarranted variations in practice","volume":"342","author":"Wennberg","year":"2011","journal-title":"BMJ"},{"issue":"7370","key":"10.1016\/j.clon.2019.12.008_bib41","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.325.7370.961","article-title":"Unwarranted variations in healthcare delivery: implications for academic medical centres","volume":"325","author":"Wennberg","year":"2002","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.clon.2019.12.008_bib42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ctrv.2014.12.010","article-title":"A\u00a0systematic review of factors influencing older adults' decision to accept or decline cancer treatment","volume":"41","author":"Puts","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"15","key":"10.1016\/j.clon.2019.12.008_bib43","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1200\/JCO.2007.15.9434","article-title":"Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?","volume":"26","author":"Keating","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2019.12.008_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/DCR.0b013e3181ff43d6","article-title":"Older patients and adjuvant therapy for colorectal cancer: surgeon knowledge, opinions, and practice","volume":"54","author":"Jorgensen","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.clon.2019.12.008_bib45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jamcollsurg.2008.10.016","article-title":"Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer","volume":"208","author":"Krzyzanowska","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2","key":"10.1016\/j.clon.2019.12.008_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.critrevonc.2010.05.009","article-title":"Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy","volume":"79","author":"Aaldriks","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.clon.2019.12.008_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.critrevonc.2010.08.004","article-title":"Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients","volume":"79","author":"Chaibi","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.clon.2019.12.008_bib48","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.dld.2015.11.023","article-title":"PRODIGE 34-FFCD 1402-ADAGE: adjuvant chemotherapy in elderly patients with resected stage III colon cancer: a randomized phase 3 trial","volume":"48","author":"Aparicio","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.clon.2019.12.008_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1470-2045(18)30646-6","article-title":"Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study","volume":"20","author":"Benitez Majano","year":"2019","journal-title":"Lancet Oncol"},{"issue":"17","key":"10.1016\/j.clon.2019.12.008_bib50","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1002\/cncr.27422","article-title":"Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil\/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis","volume":"118","author":"Sanoff","year":"2012","journal-title":"Cancer"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655519305382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655519305382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:47:37Z","timestamp":1760543257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655519305382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0936655519305382"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2019.12.008","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2019.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}